TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Belach Bioteknik AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
9,774
|
7,374
|
31,805 |
| Financial expenses |
67
|
35
|
38 |
| Earnings before taxes |
-428
|
-1,972
|
5,679 |
| EBITDA |
-347
|
-1,843
|
5,813 |
| Total assets |
10,104
|
11,429
|
14,218 |
| Current assets |
7,540
|
8,753
|
13,728 |
| Current liabilities |
776
|
1,627
|
2,392 |
| Equity capital |
9,052
|
9,480
|
11,171 |
| - share capital |
500
|
500
|
500 |
| Employees (average) |
5
|
5
|
5 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
89.6%
|
82.9%
|
78.6% |
| Turnover per employee |
1,955
|
1,475
|
6,361 |
| Profit as a percentage of turnover |
-4.4%
|
-26.7%
|
17.9% |
| Return on assets (ROA) |
-3.6%
|
-16.9%
|
40.2% |
| Current ratio |
971.6%
|
538.0%
|
573.9% |
| Return on equity (ROE) |
-4.7%
|
-20.8%
|
50.8% |
| Change turnover |
2,400
|
-24,431
|
17,633 |
| Change turnover % |
33%
|
-77%
|
124% |
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % |
0%
|
0%
|
-17% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.